LifeMap Sciences Limited

Company Overview

Snapshot

Founded in April 2011, LifeMap Sciences Limited operates with 1–10 employees. The company focuses on developing and commercializing the GeneCards Suite Knowledgebase. In March 2025, the company ceased to operate.

Business overview

LifeMap Sciences develops and commercializes the GeneCards Suite Knowledgebase, an integrated biomedical database that consolidates information from over 120 sources. This technology enables researchers to navigate and understand human genes, genetic variants, proteins, cells, biological pathways, diseases, and their interrelationships. The company serves the health tech and life sciences sectors, operating within digital healthcare and medical decision support categories.

Strategic signal

In March 2025, LifeMap Sciences ceased to operate, indicating a significant shift in its business trajectory. This event signals to investors and innovation teams that the company is no longer an active entity in the health tech and life sciences market.

Company Intelligence Q&A

What is the primary product of LifeMap Sciences?

LifeMap Sciences develops and commercializes the GeneCards Suite Knowledgebase, which integrates information from over 120 sources to help researchers navigate human genes, genetic variants, proteins, cells, biological pathways, and diseases.

What was the operational status of LifeMap Sciences in March 2025?

In March 2025, LifeMap Sciences ceased to operate, transitioning to a non-active status.

When did LifeMap Sciences announce a strategic partnership with Biocompare?

In November 2018, Biocompare and LifeMap Sciences announced a strategic partnership.

What strategic collaboration did LifeMap Sciences announce in March 2019?

In March 2019, LifeMap Sciences and iCarbonX Research Shenzhen announced a strategic collaboration.

What partnership did LifeMap Sciences form in December 2015?

In December 2015, LifeMap Sciences partnered with MedGenome to enrich NGS analysis reporting with oncology data.